Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.
Eero RissanenKelsey CarterSteven CiceroJohn FickeMarie KijewskiMi-Ae ParkJoseph KijewskiEmily SternTanuja ChitnisDavid SilbersweigHoward L WeinerChun K KimJennifer LyonsJoshua P KleinShamik BhattacharyyaTarun SinghalPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
This study provides Class II evidence that semiquantitative measures of putaminal metabolism on PET can differentiate patients with LGI1-AE from patients without LGI1-AE, patients with AD, or NCs.